Defibrillators (global market)

Cardiodefibrillators

Main article: Cardiodefibrillators

2021: Defibrillator market valued at $12.87 billion

According to the results of 2021, the volume of the global defibrillator market reached $12.87 billion. This is evidenced by the data of ResearchAndMarkets analysts, released on December 6, 2021.

Experts did not specify the dynamics in comparison with 2020, but noted that the demand for defibrillators has increased and continues to increase due to the following factors:

• people's awareness of the importance of good heart health;
• an increase in the number of heart diseases in the world;
• legislative reforms.

At the same time, researchers called the restraints for the defibrillators market:

• lack of developed health infrastructure in some regions;
• high cost of equipment;
• a weak policy of reimbursing medical institutions for the purchase of medical equipment, including defibrillators.

Defibrillator market estimated at $12.87 billion

The American Heart Association said that thanks to the use of defibrillators, about 20 thousand lives are saved annually, and proposed that the so-called automatic external defibrillators (AND) be provided in residential complexes, transport hubs and large public institutions.

According to the British Society of Cardiology, in the absence of timely care for a heart attack - which should be provided in a matter of minutes - only one patient out of ten survives. According to experts, the installation of the AND in public places can save up to 80,000 lives a year.

The study also examines the impact of the COVID-19 coronavirus pandemic on the defibrillator market. According to experts, coronavirus infection can affect the cardiovascular system, leading to myocardial damage, arrhythmias, intravascular thrombosis and sudden cardiac death. Initial reports recommended a temporal association between COVID-19 activity and cardiac arrest in the community and in hospital settings.

Among patients hospitalized with COVID-19 infection, life-threatening arrhythmias were repeatedly recorded. Sudden cardiac arrest (BCC) in patients with COVID-19 is alarming for physicians. The number of defibrillator shock procedures increased during higher COVID-19 activity.

Medtronic, Boston Scientific, Philips Healthcare - major manufacturers of defibrillators

Analysts named the following companies as the largest manufacturers of defibrillators:

• Medtronic;
• Boston Scientific;
• Philips Healthcare;
• Nihon Kohden;
• Asahi Kasei.

According to analysts, most of the supplies of automatic external defibrillators come from hospitals. At the same time, in the segment of equipment installed in public places, the largest increase is expected due to the increase in the number of cases of sudden cardiac arrest worldwide.

North America was the leader in the volume of purchases of the AND in 2021 with a share of about 30%. This was due to an increase in the proportion of the elderly population, an increase in the number of people dying due to cardiac arrest, and a growing focus on technological advances in defibrillators.

According to the forecast of ResearchAndMarkets, the volume of the global defibrillator market in the period from 2021 to 2027 will grow by an average of 5.76% annually and by the end of this period of time will reach $12.87 billion.

Experts emphasize that defibrillators are extremely useful in sudden cardiac arrest, and the COVID-19 pandemic has only increased the effect of this factor on the market. Most likely, its timely supportive state regulation and growing demand as a whole will contribute to a tangible upturn in the defibrillator market in the coming years, according to a study released in early December 2021.^[1]

Notes